Pages that link to "Item:Q5280188"
From MaRDI portal
The following pages link to Interim evaluation of efficacy or futility in group‐sequential trials with multiple co‐primary endpoints (Q5280188):
Displaying 8 items.
- Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables (Q2919476) (← links)
- Evaluating Co‐primary Endpoints Collectively in Clinical Trials (Q5123158) (← links)
- Group-Sequential Clinical Trials with Multiple Co-Objectives (Q5741295) (← links)
- Simultaneous population enrichment and endpoint selection in phase 3 randomized controlled trials: An adaptive group sequential design with two binary alternative primary endpoints (Q6549223) (← links)
- Adaptive group-sequential design with population enrichment in phase 3 randomized controlled trials with two binary co-primary endpoints (Q6625194) (← links)
- A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components (Q6625610) (← links)
- Group sequential designs for clinical trials with bivariate endpoints (Q6629838) (← links)
- Group sequential two-stage preference designs (Q6630272) (← links)
